Birthday Fundraising
Mark your special day, whilst fundraising for people with inherited sight loss.
Search results
Mark your special day, whilst fundraising for people with inherited sight loss.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Nanoscope Therapeutics has announced positive results from their two year randomised controlled phase 2b optogenetic therapy trial for late-stage retinitis pigmentosa (RP).
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
Our community are the reason we are able to continue supporting those with inherited sight-loss conditions through research and practical support.
These are some of the most commonly asked questions about volunteering for our charity.
During Loneliness Awareness Week, we're hosting a special webinar to address the challenges faced by individuals with sight loss when it comes to travel and mobility.